(Q73786574)

English

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Ma

scientific article published on 01 March 2001

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Mar

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

stem cell transplantation

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Jesús San Miguel

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

4

object named as

Ljungman P

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Anthony H. Goldstone

18

object named as

Goldstone AH

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Björkstrand B

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Svensson H

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Goldschmidt H

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Apperley J

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Mandelli F

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Marcus R

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Boogaerts M

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Alegre A

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Remes K

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Cornelissen JJ

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Bladé J

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Lenhoff S

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Iriondo A

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Carlson K

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Littlewood T

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Schattenberg A

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Gahrton G

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

511-515

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11313685%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1702826

0 references

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon therapy in myelomatosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy, glucocorticoids, and interferon alfa in the treatment of multiple myeloma: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alpha for induction and maintenance in multiple myeloma: results of two multicenter randomized trials and summary of other studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC trial of alpha2b-interferon maintenance therapy in first plateau phase of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient preferences for interferon alfa in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702826

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73786574&oldid=1759766799"